Heterocyclic amide derivative and medicine containing same
US-2015284375-A1 · Oct 8, 2015 · US
US10179782B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10179782-B2 |
| Application number | US-201615042310-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 12, 2016 |
| Priority date | Feb 15, 2015 |
| Publication date | Jan 15, 2019 |
| Grant date | Jan 15, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention is concerned with the compounds of formula I: and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain or asthma.
Opening claim text (preview).
We claim: 1. A compound selected from: or a pharmaceutically acceptable salt thereof. 2. The compound: or a pharmaceutically acceptable salt thereof. 3. The compound: or a pharmaceutically acceptable salt thereof. 4. The compound: or a pharmaceutically acceptable salt thereof. 5. The compound: or a pharmaceutically acceptable salt thereof. 6. The compound: or a pharmaceutically acceptable salt thereof. 7. The compound: or a pharmaceutically acceptable salt thereof. 8. The compound: or a pharmaceutically acceptable salt thereof. 9. The compound: or a pharmaceutically acceptable salt thereof. 10. A pharmaceutical composition, comprising a compound as described in claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Otologicals · CPC title
Centrally acting analgesics, e.g. opioids · CPC title
Drugs for disorders of the nervous system · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.